Evidence map›Paper›PMID 37069979›Full record

ArticleKidney international reports2023

Pregnancy History and Kidney Disease Progression Among Women Enrolled in Cure Glomerulonephropathy.

Monica L Reynolds, Andrea L Oliverio, Jarcy Zee, Elizabeth M Hendren, Michelle M O'Shaughnessy, Isabelle Ayoub, Salem Almaani, Tetyana L Vasylyeva, Katherine E Twombley, Shikha Wadhwani and 10 more

Open access · goldAbstract read
In one paragraph

Article in Kidney international reports, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
3.5field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 12 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Kidney disease and reproductive health.Nature reviews. Nephrology · 2025
    Review
  5. Review
  6. Article
  7. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

20 authors at 17 institutions in 3 countries.

Monica L ReynoldsDivision of Nephrology and Hypertension, University of North Carolina Kidney Center, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA.
Andrea L OliverioDepartment of Internal Medicine, Division of Nephrology, University of Michigan, Ann Arbor, Michigan, USA.
Jarcy ZeeDepartment of Biostatistics, Epidemiology, and Informatics, University of Pennsylvania, and Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, USA.
Elizabeth M HendrenDivision of Nephrology, Center for Glomerular Diseases, Columbia University Irving Medical Center, New York, New York, USA.
Michelle M O'ShaughnessyDepartment of Renal Medicine, Cork University Hospital, Wilton, Cork, Ireland.
Isabelle AyoubDivision of Nephrology, The Ohio State University Wexner Medical Center, Columbus, Ohio, USA.
Salem AlmaaniDivision of Nephrology, The Ohio State University Wexner Medical Center, Columbus, Ohio, USA.
Tetyana L VasylyevaDivision of Nephrology, Department of Pediatrics, Texas Tech University Health Sciences Center, Lubbock, Texas, USA.
Katherine E TwombleyDepartment of Pediatrics, Medical University of South Carolina, Charleston, South Carolina, USA.
Shikha WadhwaniDivision of Nephrology and Hypertension, Feinberg School of Medicine, Northwestern University, Chicago, Illinois, USA.
Julia M SteinkeDivision of Medical Subspecialties, Section of Pediatric Nephrology, Helen DeVos Children's Hospital, Grand Rapids, Michigan and Department of Pediatrics and Human Development, Michigan State University, Lansing, Michigan, USA.
Dana V RizkDivision of Nephrology, University of Alabama at Birmingham, Birmingham, Alabama, USA.
Meryl WaldmanKidney Disease Branch, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, Maryland, USA.
Margaret E HelmuthArbor Research Collaborative for Health, Ann Arbor, Michigan, USA.
Carmen Avila-CasadoDepartment of Pathology, Toronto General Hospital, University Health Network, Toronto, Ontario, Canada.
Nada AlachkarDivision of Nephrology, Department of Medicine, The Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
Carla M NesterDivision of Nephrology, Departments of Internal Medicine and Pediatrics, Carver College of Medicine, University of Iowa, Iowa City, Iowa, USA.
Vimal K DerebailDivision of Nephrology and Hypertension, University of North Carolina Kidney Center, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA.
Michelle A HladunewichDivisions of Nephrology and Obstetrics, Sunnybrook Health Sciences Center, University of Toronto, Toronto, Ontario, Canada.
Laura H MarianiDepartment of Internal Medicine, Division of Nephrology, University of Michigan, Ann Arbor, Michigan, USA.
The Ohio State University Wexner Medical Center · USUniversity of Michigan · USUniversity of North Carolina at Chapel Hill · USArbor Research Collaborative for Health · USChildren's Hospital of Philadelphia · USColumbia University Irving Medical Center · USCork University Hospital · IEHelen DeVos Children's Hospital · USJohns Hopkins University · USMedical University of South Carolina · USNational Institutes of Health · USNorthwestern University · USSunnybrook Health Science Centre · CATexas Tech University · USUniversity Health Network · CAUniversity of Alabama at Birmingham · USUniversity of Iowa · US

Funding

CureGNU24DK100845 · NIDDK · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI CRYSTAL A. GADEGBEKU, Laura H Mariani · 2019 to 2026
$12.1M
The Columbia PCC for CureGN: the Cure Glomerulonephropathy networkU01DK100876 · NIDDK · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI Andrew Stephen Bomback, ALI G GHARAVI · 2019 to 2026
$8.5M
CureGN-Penn PCCU01DK100846 · NIDDK · UNIVERSITY OF PENNSYLVANIA · PI LAWRENCE B. HOLZMAN · 2019 to 2026
$8.3M
CUREGN 3.0 - Pediatric Nephrology Consortium - PCCU01DK100866 · NIDDK · RESEARCH INST NATIONWIDE CHILDREN'S HOSP · PI Laurence A Greenbaum, Jon Klein · 2019 to 2026
$7.7M
CureGN-3: UNCPCCU01DK100867 · NIDDK · UNIV OF NORTH CAROLINA CHAPEL HILL · PI Vimal Kumar Derebail, Ronald J Falk · 2019 to 2026
$6.7M
GDPrimeUM1DK100845 · NIDDK · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI GIPSON, DEBBIE S, KRETZLER, MATTHIAS · 2013 to 2018
$6.4M
Primary Outcomes in Glomerulonephritis Study (PROGRESS)UM1DK100846 · NIDDK · UNIVERSITY OF PENNSYLVANIA · PI HOLZMAN, LAWRENCE B. · 2013 to 2018
$5.8M
Integrative Proteomics & Metabolomics for Pediatric Glomerula Disease BiomarkersUM1DK100866 · NIDDK · RESEARCH INST NATIONWIDE CHILDREN'S HOSP · PI GREENBAUM, LAURENCE A, SMOYER, WILLIAM E · 2013 to 2018
$5.5M
Advancing Clinical Research in Primary Glomerular Diseases (UM1)UM1DK100876 · NIDDK · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI GHARAVI, ALI G · 2013 to 2018
$4.8M
GDCN Clinical Center-Advancing Clinical Research in Primary Glomerular DiseasesUM1DK100867 · NIDDK · UNIV OF NORTH CAROLINA CHAPEL HILL · PI FALK, RONALD J · 2013 to 2018
$4.0M
Developing a decision aid for reproductive health for women with kidney diseaseK23DK123413 · NIDDK · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI OLIVERIO, ANDREA L · 2020 to 2024
$1.1M
NIDDK NIH HHS K23 DK123413NIDDK NIH HHS U01 DK100846NIDDK NIH HHS U01 DK100866NIDDK NIH HHS U01 DK100867NIDDK NIH HHS U01 DK100876NIDDK NIH HHS U24 DK100845NIDDK NIH HHS UM1 DK100845NIDDK NIH HHS UM1 DK100846NIDDK NIH HHS UM1 DK100866NIDDK NIH HHS UM1 DK100867NIDDK NIH HHS UM1 DK100876
6 · The paper itself

Abstract

Introduction: Preeclampsia increases the risk for future chronic kidney disease (CKD). Among those diagnosed with CKD, it is unclear whether a prior history of preeclampsia, or other complications in pregnancy, negatively impact kidney disease progression. In this longitudinal analysis, we assessed kidney disease progression among women with glomerular disease with and without a history of a complicated pregnancy. Methods: Adult women enrolled in the Cure Glomerulonephropathy study (CureGN) were classified based on a history of a complicated pregnancy (defined by presence of worsening kidney function, proteinuria, or blood pressure; or a diagnosis of preeclampsia, eclampsia, or hemolysis, elevated liver enzymes, and low platelets [HELLP] syndrome), pregnancy without these complications, or no pregnancy history at CureGN enrollment. Linear mixed models were used to assess estimated glomerular filtration rate (eGFR) trajectories and urine protein-to-creatinine ratios (UPCRs) from enrollment. Results: Over a median follow-up period of 36 months, the adjusted decline in eGFR was greater in women with a history of a complicated pregnancy compared to those with uncomplicated or no pregnancies (-1.96 [-2.67, -1.26] vs. -0.80 [-1.19, -0.42] and -0.64 [-1.17, -0.11] ml/min per 1.73 m Conclusions: A history of complicated pregnancy was associated with greater eGFR decline in the years following glomerulonephropathy (GN) diagnosis. A detailed obstetric history may inform counseling regarding disease progression in women with glomerular disease. Continued research is necessary to better understand pathophysiologic mechanisms by which complicated pregnancies contribute to glomerular disease progression.

Indexed as

Chronic kidney diseaseGlomerular diseasePregnancy

Identifiers

PMID37069979
PMCPMC10105239
OpenAlexW4318679818

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.